Hot Investor Mandate: Corporate Venture Arm’s Healthcare Fund Primarily Invests in Therapeutics, with Strong Interests in Immunology & Oncology and Novel Platforms

29 Oct

A corporate venture arm invests across multiple funds, with each fund focused on a sector of strategic interest to the parent organization. The firm typically leads or co-leads rounds as a member of a syndicate of investors. The firm is actively seeking new investment opportunities across all funds.

The firm’s healthcare fund is looking for early stage companies working primarily within therapeutics. The firm seeks to invest in areas of strategic interest to its parent company including Immunology (Autoimmune), Oncology, Immuno-oncology, and Fertility. The firm generally looks for companies with novel first-in-class preclinical stage assets as well as novel platform technologies.

The firm is looking for privately held companies with experienced management teams able to take innovative solutions into commercially viable products. The firm looks to take an active role following investing taking a board seat, and is able to invest globally.

If you are interested in more information about this investor and other investors tracked by LSN, please email mandates@lifesciencenation.com.

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Google photo

You are commenting using your Google account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s

%d bloggers like this: